Two randomized trials of linaclotide for chronic constipation. - Wikidata - awgldk - TriplyDB

Two randomized trials of linaclotide for chronic constipation.

Two randomized trials of linaclotide for chronic constipation.

http://www.wikidata.org/entity/Q43332645

about

Guidelines for the Diagnosis and Treatment of Chronic Functional Constipation in Korea, 2015 Revised Edition Irritable bowel syndrome: new insights into symptom mechanisms and advances in treatment Recent Updates on the Treatment of Constipation Abdominal bloating: pathophysiology and treatment Linaclotide: a new option for the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation in adults Measuring response in the gastrointestinal tract in systemic sclerosis Treatment for constipation: new and old pharmacological strategies Novel therapies for constipation GUCY2C opposes systemic genotoxic tumorigenesis by regulating AKT-dependent intestinal barrier integrity Elobixibat and its potential role in chronic idiopathic constipation Persistent constipation and abdominal adverse events with newer treatments for constipation.Emerging Pharmacologic Therapies for Constipation-predominant Irritable Bowel Syndrome and Chronic Constipation.Sildenafil normalizes bowel transit in preclinical models of constipation Understanding and treating refractory constipation.Linaclotide: A new drug for the treatment of chronic constipation and irritable bowel syndrome with constipation Luminally Acting Agents for Constipation Treatment: A Review Based on Literatures and Patents.Constipation-predominant irritable bowel syndrome: a review of current and emerging drug therapies.Effects of lubiprostone on pacemaker activity of interstitial cells of cajal from the mouse colon.Impact of linaclotide treatment on work productivity and activity impairment in adults with irritable bowel syndrome with constipation: results from 2 randomized, double-blind, placebo-controlled phase 3 trials.Chronic constipation in the elderly.Psychometric validation of patient-reported outcome measures assessing chronic constipation.Randomised clinical trials: linaclotide phase 3 studies in IBS-C - a prespecified further analysis based on European Medicines Agency-specified endpoints.American Gastroenterological Association technical review on constipation.Metabolic and toxicological considerations for the latest drugs used to treat irritable bowel syndrome.Effect of linaclotide in irritable bowel syndrome with constipation (IBS-C): a systematic review and meta-analysis.The paracrine hormone for the GUCY2C tumor suppressor, guanylin, is universally lost in colorectal cancer Current and emerging treatments for irritable bowel syndrome with constipation and chronic idiopathic constipation: focus on prosecretory agents.Treatment of Chronic Constipation: Prescription Medications and Surgical Therapies.The impact of abdominal pain on global measures in patients with chronic idiopathic constipation, before and after treatment with linaclotide: a pooled analysis of two randomised, double-blind, placebo-controlled, phase 3 trials Larazotide acetate for persistent symptoms of celiac disease despite a gluten-free diet: a randomized controlled trial.Linaclotide in Chronic Idiopathic Constipation Patients with Moderate to Severe Abdominal Bloating: A Randomized, Controlled Trial Advancing treatment options for chronic idiopathic constipation.Medical management of constipation.Chronic constipation: new diagnostic and treatment approaches Linaclotide: evidence for its potential use in irritable bowel syndrome and chronic constipation.Resting anal pressure, not outlet obstruction or transit, predicts healthcare utilization in chronic constipation: a retrospective cohort analysis.A 12-week, randomized, controlled trial with a 4-week randomized withdrawal period to evaluate the efficacy and safety of linaclotide in irritable bowel syndrome with constipation Effective Constipation Treatment Changes More Than Bowel Frequency: A Systematic Review and Meta-Analysis.Randomised controlled trial of mesalazine in IBS.Linaclotide (Linzess) for Irritable Bowel syndrome With Constipation and For Chronic Idiopathic Constipation

P2860

Q26745952-8D50FDEE-2690-4972-B19A-0DD636C8B6AB Q26751193-D1F91D5F-C09E-45B9-B0E3-025EBE2579ED Q26820242-8A4542EF-9309-42FD-936E-F428434E202A Q26851622-F15D2E6F-B713-4379-B859-0CBA7E4BFD08 Q27010449-1FA6DEAB-5234-467F-9268-6A9A8DB9E7F8 Q27022416-9B667647-90F7-4BAF-AFDF-F578AA16B00A Q27027346-10CB72A7-2E80-4897-B13D-38089FB4206F Q27027873-ED745B06-A756-4A32-B5EB-AD11C9E3CAF9 Q27308895-4988E75B-30EB-4500-8E70-B942BEBFC6A2 Q28244603-B4DDB9D9-EFD7-453C-96F2-D80CDF2CEC8F Q33468562-5B5E113D-30E8-4FB7-9537-788BA2DA1F29 Q33586854-C84FCF17-4BE3-4C6E-9A9C-A80AFF42D5B0 Q33610799-451D9CED-F100-4033-A0CA-95534AB7CDBD Q33621273-8CF2869C-3786-4C23-A54C-498D9544C265 Q33695487-3DF0C2D4-4FE2-4A55-A59A-751E60675E4E Q33854983-71BB135D-6C24-461B-8025-4CDDEBC2945B Q33958710-326016E4-8F2C-49AF-BDC7-781D01C1EE57 Q34097910-ACF4FAD1-3038-4556-9D8E-6CFFA521B2EB Q34179472-75D12B69-50FD-4079-9BEF-6262A61D39AD Q34223161-1FA2F83E-5689-4128-99A4-F0DFCD83C5D2 Q34293147-838048D4-1DB9-4DF5-8586-AA621FB8F41C Q34309302-959A7359-DAA4-43A3-B404-403D26D7B42D Q34319119-ACDB8613-650C-4FB0-AD27-DABABE5479DB Q34323319-048D57BB-5A9B-4899-AE2F-4477699E8B28 Q34392861-0E2ED871-035D-44A4-A76F-1830B71E055C Q34458591-99A66F28-CCDC-4E1F-AD66-72329C1A87FB Q34478089-1902ACB9-20C2-40CA-8F67-518B392C15B1 Q34522966-664287F2-E969-4570-B07A-B89F7BC8B65A Q34782198-1E21343B-CE59-4BEC-9070-82FE5E94DC22 Q35655989-7A8EB147-59AA-47A6-A756-1D6553186413 Q35723125-21F5398D-C6A5-4418-A659-637C7D09F32F Q35858864-7C890E54-B983-4390-BBB2-F8DC52E67D23 Q35948228-133D78ED-5CF2-4CA2-BCC4-6D9BD1EC776A Q36072686-D8B69FA6-2491-4904-87E2-ED32D0A0C70D Q36092886-CD7053B9-3B77-416A-9FA9-34C57B7179B0 Q36096138-2880CCA6-047E-4965-AA19-B7EC803698FD Q36417684-E742EFAB-6D6A-4920-83CD-20F6F827DAB1 Q36426025-16CF46DC-7070-4D06-80FE-78F95EF48A46 Q36475502-5C2B391E-F09C-4BB8-923A-46AD771FCF9F Q36801233-77870B86-8AE5-4287-8FF6-771018749103

P2860

Two randomized trials of linaclotide for chronic constipation.

http://www.wikidata.org/entity/Q43332645

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

Two randomized trials of linaclotide for chronic constipation.

@en

Two randomized trials of linaclotide for chronic constipation.

@nl

type

label

Two randomized trials of linaclotide for chronic constipation.

@en

Two randomized trials of linaclotide for chronic constipation.

@nl

prefLabel

Two randomized trials of linaclotide for chronic constipation.

@en

Two randomized trials of linaclotide for chronic constipation.

@nl

P1433

Q43332645-705F7961-96D2-4932-B712-647C4E10B2DC

P1476

Q43332645-18745498-BF4F-4650-92E9-C0D88E177DC0

P2093

Q43332645-0166BBC5-F593-4FE2-A188-1B41C958B261

Q43332645-0AC4AC99-77E7-4A38-A3C1-E559D85AF70A

Q43332645-17A5A80C-86EC-4E4D-BD5F-4C0B6B07FA6D

Q43332645-21E2C9E7-3193-47DF-A4F7-4AF4C9501853

Q43332645-26D9CFF4-7501-41C5-B746-2F149A93A121

Q43332645-4FB3798C-9694-4179-8F7C-0BD35ED3F457

Q43332645-5AF836A7-A4A6-4BF9-9987-27BE660428AB

Q43332645-5CB34E4A-0B1B-43B6-9987-17945958EDD8

Q43332645-65DD2D91-6E4A-4887-8702-8370585074C0

Q43332645-6DBE8B9C-74C8-4602-87AB-7ACDE7DC0149

P304

Q43332645-1C94C64B-4D67-44C2-A0FA-F8F34811F140

P31

Q43332645-D2602E69-E0CF-4322-9929-FFDFE16D1615

P356

Q43332645-FA40D3AA-F17A-4AA3-8506-41DB87F2380B

P407

Q43332645-065F8F21-2794-43FB-B387-A21DEF3E538B

P433

Q43332645-7D8DCF57-88CA-47BA-8DFD-0B1863C1DB44

P478

Q43332645-0E9DC606-3BA5-4F37-AE75-E7824F7BC6C0

P577

Q43332645-2412ABF1-75EE-4354-AFEC-E97DB74C0632

P698

Q43332645-E04599C9-FF24-4DBC-9317-BE51BB4A8832

P921

Q43332645-DF1EFD1D-317D-4D3F-A960-15685E7ABAD2

P356

P1433

The New England Journal of Medicine

P1476

Two randomized trials of linaclotide for chronic constipation.

@en

P2093

Anthony J Lembo

http://www.w3.org/2001/XMLSchema#string

Bernard J Lavins

http://www.w3.org/2001/XMLSchema#string

Brenda I Jeglinski

http://www.w3.org/2001/XMLSchema#string

Caroline B Kurtz

http://www.w3.org/2001/XMLSchema#string

Donald A Fitch

http://www.w3.org/2001/XMLSchema#string

Harvey A Schneier

http://www.w3.org/2001/XMLSchema#string

James E MacDougall

http://www.w3.org/2001/XMLSchema#string

James Z Shao

http://www.w3.org/2001/XMLSchema#string

Jeffrey M Johnston

http://www.w3.org/2001/XMLSchema#string

Mark G Currie

http://www.w3.org/2001/XMLSchema#string

P304

527-536

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA1010863

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

365

http://www.w3.org/2001/XMLSchema#string

P577

2011-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21830967

http://www.w3.org/2001/XMLSchema#string

P921